Consistent Real-World Efficacy of Ofatumumab Therapy for Multiple Sclerosis - NeurologyLive

Retrieved on: 2024-03-15 21:10:06

Tags for this article:

Click the tags to see associated articles and topics

Consistent Real-World Efficacy of Ofatumumab Therapy for Multiple Sclerosis - NeurologyLive. View article details on hiswai:

Excerpt

Ofatumumab (Kesimpta; Novartis), an FDA-approved anti-CD20 monoclonal antibody, has demonstrated efficacy in reducing incidence of relapse for ...

Article found on: www.neurologylive.com